Yogi Zone

Useful articles for your finance management by our team of experts

Sun Pharma Stock Review – Nifty 50

0 Flares 0 Flares ×

Stock Name – Sun Pharmaceutical

Listed Exchange: NSE, BSE, BSE Healthcare


P/E or Price to Equity Ratio: 643.99

EPS or Earnings per Share: 0.89

P/B or Price to book value ratio: 13.76

Market Capitalization: Rs. 1.1 lakh crore

Current Price on NSE – 573.15

52 Week Low – 347.10

52 Week High – 650

Our Review of Sun Pharma Stock

Sun Pharma is a leader in the health care sector with a market capitalization of more than Rs.1.1 lakh crore. If you had invested in the stock 5 years ago, you would have invested at a level of 105. It implies an extraordinary return of 4.5 times the invested amount.

Though the company has strong financials, the stock seems to be overly priced as of now. It could be a decent bet in the long run. But in the short term, it could face volatility.

0 Flares Facebook 0 Google+ 0 Twitter 0 Email -- 0 Flares ×